MODEL RELEASED. Young woman blowing nose on tissue. How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis? Azelastine HCl 0 ...

September 2, 2009 — The US Food and Drug Administration has approved azelastine HCl 0.15% nasal spray (Astepro Once-Daily; Meda AB) for the treatment of seasonal and perennial allergic rhinitis in ...

The JAMA Internal Medicine journal published a new clinical study that suggests a common over-the-counter nasal spray, which contains azelastine, can offer significant protection from COVID-19. The ...

SAN ANTONIO — Azelastine hydrochloride and fluticasone propionate dual agent nasal spray effectively reduced ocular itch and nasal congestion in patients with seasonal allergic rhinitis, according to ...

The over-the-counter allergy spray azelastine reduced the odds of getting COVID by two-thirds in a small clinical trial. A new study showed that azelastine, an over-the-counter nasal spray, helped ...

November 13, 2009 (San Diego, California) — A combination of azelastine hydrochloride and fluticasone propionate nasal sprays administered in a single delivery device can significantly improve both ...

Details concerning the Azelastine Hydrochloride combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, ...

Meda announced today positive results from a Phase III clinical trial of Dymista (also known as MP29-02), a novel formulation of azelastine hydrochloride and fluticasone propionate, in patients with ...

Researchers say people using a common allergy nasal spray, azelastine, were 69% less likely to contract COVID-19. Participants in the trial were also 71% less likely to catch the common cold than ...

In a study published on the bioRxiv* preprint server, researchers from the University of Pécs, University of Vienna, and CEBINA GmbH, Vienna, show the ability of the antihistamine azelastine to ...

Girl blowing nose, allergic rhinitis, nasal congestion The primary endpoint was time from baseline to azelastine’s onset of the usefulness, which researchers assessed by comparing azelastine and ...